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A B S T R A C T
Aim: We evaluated a cohort of advanced hypopharyngeal squamous cell carcinoma, treated with conservative
surgery, reconstruction with infrahyoid ﬂap and radio-chemotherapy.
Methods: We used partial pharyngo-laryngectomy and radio-chemotherapy to treat ﬁfty-seven patients with
stage III–IV hypopharyngeal SCC from November 1994 to December 2011. Clinical examination and speech
therapy evaluation were used for estimation of laryngeal function.
Results: All patients received a partial pharyngo-laryngectomy. All patients underwent neck dissection; 56 pa-
tients received bilateral neck dissection. Reconstruction was achieved by infra-hyoid ﬂap. Five-year overall and
disease-speciﬁc survival rates were 54.4% and 61.4%, respectively. Successful laryngeal function preservation
with complete ﬁve-year remission was achieved in 44% of the patients.
Conclusion: Selected even if advanced carcinomas of the hypopharynx maybe treated with partial pharyngo-
laryngectomy with reconstruction with pedicled ﬂap. Both oncological and functional results showed a good
outcome.
1. Introduction
Squamous cell carcinoma of the hypopharynx (HPC) is the least
common of the upper aerodigestive cancers, representing 5% of head-
and-neck cancers [1]. Because of factors such as advanced disease,
patient comorbidity, and a high incidence of distant metastases, pa-
tients with HPC have the worst prognosis of all head-and-neck cancer
patients [1–4]. Hypopharyngeal cancer is most common in men in their
mid-60s and with a lower socioeconomic status. It is caused by alcohol
or smoking (or both). Many studies reported a low proportion
(0%–11%) of p16 HPV-positive tumors in patients with HPC [5,6].
Treatment has varied over time and between jurisdictions, but essen-
tially, until the late 1990s, the typical treatments were radiotherapy,
surgery, or a combination of the two, with no evidence of the super-
iority of one treatment modality for all cases [7]. With the advent,
based on randomized trials and meta-analyses of concomitant che-
moradiotherapy (CCRT) for head-and-neck squamous cell carcinomas
[8–11]. As oncologists have moved more toward the concept of organ
preservation, other treatments have included induction chemor-
adiotherapy [3,12,13] and transoral laser surgery [14,15]. A complete
review of treatment options published by Takes et al. [16] concluded
that more evidence was needed to determine optimal treatment and
that “treatments should be individualized by knowledgeable multi-
disciplinary teams”. Deﬁnitive radiation therapy is generally considered
an eﬀective therapeutic approach for T1 and selected T2 hypophar-
yngeal carcinoma especially in presence of comorbidities [17]. In ad-
vanced stage diseases must be considered a more extensive treatment
such as surgery and CCRT [18]. Hypopharyngeal reconstruction has
been a major challenge over the years. Every partial laryngectomy
aiming to maintain laryngeal functions must guarantee adequate
airway together with at least one functioning crico-arytenoid unit, in
horizontal partial laryngeal surgery these requirements are achieved
with an end to end reconstruction of the airway by means of a pexy, but
in case of hypopharyngeal-laryngeal resection the resulting defect is
more complex and the transposition of a ﬂap is usually required. In
literature several techniques deal with the reconstruction after total
laryngectomy with circumferential or partial hypopharyngeal resection,
but very few reports describe the reconstruction of pharyngo-laryngeal
defects resulting from HPC resection and laryngeal preservation sur-
gery. Many surgical techniques has been developed and purposed [19]
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ranging from deltopectoral ﬂap [20] to pectoralis major ﬂap [21–23] to
gastric pull up. With the more recent rise of microvascular and free ﬂap
reconstruction both surgical approaches and functional results in hy-
popharyngeal cancer, for “patch” or circumferential reconstruction,
have changed have improved. Microvascular ﬂaps commonly used are
jejunum, radial forearm free ﬂap, or anterolateral thigh ﬂap [24]. We
report our series of HPC treated with laryngeal conservation surgery
where the reconstruction was eﬀectively provided by the infrahyoid
ﬂap. This ﬂap has proven its utility in various head and neck sites and it
presents several characteristics that make it very suitable for phar-
yngolaryngeal reconstruction.
2. Patients and methods
2.1. Patients
Criteria for patient selection for this study had included: (1) squa-
mous cell carcinoma of the hypopharynx, (2) stages III and IV status, (3)
absence of inﬁltration of the apex of the pyriform sinus or retro-cricoid
and parapharyngeal regions and (4) reconstruction obtained by means
of infrahyoid ﬂap. From November 1996 to December 2014, 57 patients
have been admitted for hypopharyngeal cancer and received formal or
extended partial supraglottic laryngo-pharyngectomy for hypophar-
yngeal squamous cell carcinoma. To obtain the results, the following
have been taken into account after re-evaluation of patients chart:
history of disease, clinical, radiological and pathologic characteristics
of lesions, post-operative complications, radiation therapy modalities,
delay for retrieval of tracheotomy and nasogastric feeding tube, com-
plications and duration of local control. The local extension of the
tumor has been evaluated preoperative by means of systematical pa-
nendoscopies. In each case, pathologic examination revealed squamous
cell carcinoma. During the panendoscopy, an endoscopic percutaneous
gastrostomy has been eventually placed in patients who presented
dysphagia or with a previewed post-operative eating rehabilitation
longer than 3weeks. Only one patient had been already treated and
presented with a post-radiotherapy relapse. Three patients among the
57 initially included died within a few weeks following the operation
and were, therefore, not taken into account for functional and loco-
regional control assessment. All of the patients included in the present
study were staged by the TNM staging system as recommended by the
2010 American Joint Committee on Cancer on clinical staging.
2.2. Surgical technique
All patients were operated on using basically two surgical proce-
dures. The ﬁrst one was the supraglottic pharyngo-laryngectomy tech-
nique described by Ogura [25]; it is suitable for tumors limited to the
medial wall of the pyriform sinus with possible extension to the ar-
yepiglottic fold. In case of lateral wall of the pyriform sinus or to pos-
terior hypopharyngeal wall involvement, the same technique had been
used, adding an extended pharyngectomy perfected by Hamoir [26]. In
case of hemilaryngeal ﬁxation, a second technique was used as de-
scribed by Urken and consisting of partial pharyngo-laryngectomy, in-
cluding the hemicricoid and hemithyroid cartilages [27]. Both techni-
ques speculate an ipsilateral thyroid gland lobectomy. Neck dissection
was bilateral in all cases. Primary closure was achieved with a local
infrahyoid muscle ﬂap in all patients.
Infrahyoid ﬂap is a myocutaneous ﬂap pedicled on the superior
thyroid vessels. Described for the ﬁrst time by Wang in 1979, technical
improvements have been introduced by Dolivet et al. [28] especially to
enhance the venous drainage and aesthetic results at the donor site.
The infrahyoid muscles included sternohyoid, thyrohyoid, ster-
nothyroid and omohyoid constitute the anatomical substratum of the
ﬂap, completed by the plathysma and the overlying skin.
A fusiform skin paddle located at the same side of the pharyngeal
resection and centred over infrahyoid muscles and the cricoid region is
outlined and is included in neck incision (Fig. 1a). The medial limit of
the ﬂap lies at the midline, the upper limit at the level of hyoid bone,
and the lower limit at the suprasternal notch. This ﬂap can measure up
to 10 cm in its greatest length and reach a distance of 15 cm around its
rotation axis. The ﬂap harvesting is fast and the donor site can be pri-
mary closed to the original operating ﬁeld when the skin paddle is
not> 5 cm.
First, skin and platysma are incised all around the skin paddle to
allow prompt choke perforator vessels opening (Fig. 1b). Infrahyoid
ﬂap harvest is normally performed after the ipsilateral neck dissection
and before tumor resection (Fig. 2a). The technique in harvesting of the
ﬂap is common to those of other districts. The surgical anatomy and the
harvesting of the infra hyoid ﬂap are well described in precedent
publications [29–31]. The ﬂap is raised from lateral to medial and from
caudal to cephal.
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Fig. 1. Left infrahyoid ﬂap.
a: Drawing of the limits of ﬂap before incision on the same side of the tumor.
The skin paddle is included in the incision of neck dissection.
b: The skin and platysma are incised all around the skin paddle to allow prompt
choke perforator vessels opening.
S. Cortese, et al. Am J Otolaryngol 40 (2019) 102271
2
The elevation starts by sectioning the sternohyoid and sternothyroid
muscles from the suprasternal notch. Then the ﬂap is elevated over the
capsule of the thyroid lobe. The cricothyroid artery and vein, the pos-
terior branch of the superior thyroid artery and vein after being ligated
and cut are harvested with the ﬂap. Medially, the linea alba is sec-
tioned. The infrahyoid muscles are released from the thyroid cartilage
plan and the hyoid bone. The hyoid insertions of the sternohyoid and
omohyoid muscles are sectioned to allow the mobility of the ﬂap and
the exposure of the pharyngolarynx. Once tumor resection completed,
the reconstruction is obtained by turning the ﬂap medially (Fig. 2b, c).
The skin paddle is sutured with reabsorbable to the remaining mucosa.
Double layer sutures are held frontward (Fig. 2d). Flap harvesting may
occur in communication with the tracheotomy and contamination to
the wound bed. To avoid this, the thyroid isthmus is simply sutured to
the subcutaneous tissue.
2.3. Adjuvant therapy
According to pN staging (positive lymph nodes, extracapsular
spread) and prognostic factors such as borderline or positive margins,
vascular and perineural involvement, post-operative adjuvant therapies
were administer to patients. Normally, patients were treated with
parallel-opposed lateral ﬁelds for the upper neck, including the primary
site and an anterior ﬁeld for the lower neck. Total dose administered
ranged from 60 to 64 Gy. Patients received daily 2 Gy fractions for
6–6.5 weeks. Chemotherapy has not been given in older patients
(> 80 years) and/or patients with severe comorbidities.
2.4. Post-operative evaluation
If the removal of tracheotomy cannula and/or feeding support de-
vices (nasogastric or gastrostomy tube) was possible, it was annotated.
As well as laryngeal preservation (ability to speak, no tracheotomy and
deglutition without symptomatic aspiration) was the functional aim; a
1-year evaluation in survived patients has been done with a special
focus on vocal function, swallowing diﬃculties and social life.
2.5. Statistical methods
All data were analyzed using Stata/SE 12.0 (StataCorp., College
Station, TX). Patient survival curves were estimated using the
Kaplan–Meier and product-limit methods. Overall survival analysis was
based on death from any cause. For the calculation of cause-speciﬁc
survival, patients were censored if death was not directly related to the
pyriform sinus cancer. Survival interval was measured from the date of
surgery in the department to last consultation, phone inquiry or death.
Comparisons between survival curves were made using the log-rank test
with a signiﬁcance level based on a p-value of< 0.05.1.
3. Results
3.1. Patient population and treatment
In the study, ﬁfty-seven patients were analyzed. All patients referred
with a squamous cell carcinoma of the hypopharynx. Baseline char-
acteristics are showed in Table 1.
All lesions had advanced stages; among them, twenty three patients
had a clinical stage III, the remaining thirty four had a stage IV tumor.
Clinical TNM evaluation is summarized in Table 2. As described before,
all patients received a partial pharyngo-laryngectomy. Forty-one pa-
tients received a partial pharyngo-laryngectomy according to Ogura/
Hamoir technique, 12 patients received an Urken's hemilaryngeal-
pharyngectomy. The remaining 4 patients received a more tailored
surgery eventually extended to base of the tongue or lateral pharyngeal
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Fig. 2. Surgical procedure.
a: The infrahyoid ﬂap [1] is elevated after neck dissection.
c, d: After tumor resection, the defect [2] is ﬁlled by performing a rotation of the ﬂap toward the inside. Double layer sutures are held frontward.
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wall. All patients underwent bilateral modiﬁed radical neck dissection
type III. Four patients received a one-side radical neck dissection.
Median operative time had been 4 h 15min ± 43min (range 3 h–6 h).
One patient had been referred for salvage treatment of recurrence after
poor response to radiation therapy, and was considered suitable for
conservation surgery. Reconstruction required in all cases a local in-
frahyoid muscle ﬂap. One patient received also a pectoral myo-cuta-
neous ﬂap to cover a defect bigger than previewed. Fifty-four patients
received post-operative radiation therapy. Thirty patients received
post-operative chemotherapy.
Pathological examination reveals a conﬁrmation of clinical stage in
44 patients (77.2%) whilst 11 patients got an upstaged lesion (19.3%)
and 2 (3.5%) a downstaged one. Pathologic examination of the resected
tumor revealed disease free margins in 46 patients (80.7%), and mi-
croscopically positive or border-line in eleven cases on the initial re-
section margins. In these cases, margins were enlarged until histologi-
cally disease free on frozen section. However, four patients had frozen
section negative margins revealed positive in the deﬁnitive evaluation.
Nodal metastases were histopathologically diagnosed in 52 patients
(91.2%), among which 15 (28.8%) had bilateral involvement and 32
(61.5%) were found to have extracapsular spread.
3.2. Complications
One patient died in the immediate post-operative course for un-
known reason while sleeping (possible acute asphyxia due to a blood
plug). Twenty-four patients presented local complications: 5 patients
were aﬀected by pneumonia; 2 hemorrhages had occurred (one needed
a surgical revision); 7 patients experienced deep wound infection, one
of those evolved in a salivary ﬁstula. The overall incidence of pharyngo-
cutaneous ﬁstula has been 5 out of 57 patients (9%), all successfully
treated with compressive dressing. Five patients needed blood trans-
fusion. None ﬂap necrosis has been seen.
3.3. Functional results
Tracheotomy tube was removed with a median delay of 18 post-
operative days (range: 7–40 days). To deﬁne the median, the patients
who underwent adjuvant therapy with a previewed risk for treatment
have been excluded.
Five patients (9%) could not remove their tracheotomy at 1-year
evaluation. Laryngeal preservation (ability to speak, no tracheotomy
and deglutition without symptomatic aspiration) was achieved in 42 of
55 functionally assessed cases (76%) at the end of the treatment.
Deglutition was assessed clinically and radiologically with modiﬁed
barium swallow. Overall, in 75% of the patients, deglutition, with the
ability to tolerate liquid and solid food was obtained.
3.4. Survival and loco-regional control
To assess the survival rate four patients have been removed, as they
were lost in follow-up before the ﬁfth year. The overall 5-years survival
rate was 50.9% (Fig. 3a).
Fifteen patients (28.3%) died because of cancer evolution, among
them 11 (20.8%) had distant metastasis and 6 (11.3%) had a loco-re-
gional recurrence. 3 (5.7%) patients died because of a second primary
tumor; 8 (15.1%) patients died for others causes such as 2 intestinal
infarction, 6 pulmonary complications). The disease free survival ob-
served in our series was 61.4% (Fig. 3b).
4. Discussion
The hypopharyngeal carcinoma remains a major issue in head and
neck cancer mainly because of late diagnosis and poor prognosis.
Table 1
Baseline patients characteristics.
Age (years, median ± SD) 58.5 ± 9.1
Male 56 (98.2%)
Female 1 (1.8%)
Stage
III 23 (40.4%)
IV 34 (59.6%)
Site
Hypopharynx 24 (42.1%)
Hypopharynx-larynx 30 (52.6%)
Hypopharynx-oropharynx 3 (5.3%)
Synchronic primary tumor 3 (5.3%)
Table 2
Clinical TNM evaluation.
T1 T2 T3 T4 Total
N 0 0 0 3 1 4
N 1 1 15 4 0 20
N 2a 0 0 4 0 4
N 2b 0 9 6 1 16
N 2c 1 4 3 3 11
N 3 0 2 0 0 2
Total 2 30 20 5 57
Fig. 3. Survival and loco-regional control.
a: Overall 5-years survival.
b: Disease free survival.
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Nowadays, total pharyngolaryngectomy (TPL) with adjuvant radiation
therapy remains the most widely used treatment in cases of high-staged
disease. However, TPL is encumbered by two main post-operative
morbidities: permanent tracheostomy with loss of voice and the de-
glutition impairment. Moreover, whatever the therapeutic modality is
used, overall 5-year survival rates, as reported in the literature, do not
exceed 50% [32–34]. During the last ﬁfty years, the treatment para-
digm for advanced hypopharyngeal cancer tends to shift from TPL to
partial surgical or endoscopically performed approaches. The partial
pharyngolaryngectomies (PLPs) were born as less traumatic minimally
invasive procedures and have oﬀered the opportunity of preserving
function of the larynx in selected cases of hypopharyngeal cancer. In
this respect, PLPs resections must encompass the tumor with adequate
margins, must ensure airway patency, and must preserve at least one
functioning crico-arytenoid unit. However, only selected cases will be
suitable for this approach but the eﬃcacy linked with tumor control of
rising nonsurgical treatments, makes them a solution to obtain an im-
proved quality of life [16] The ﬁrst PLP reports advocated an im-
mediate closure only with remaining pharyngeal mucosa and even-
tually a skin graft [25,35]. If this may be feasible with small defects, it is
not acceptable for bigger mucosal resections in order to avoid phar-
yngo-cutaneous ﬁstulas. To improve the functional results in the last
decades a rising importance has been given to reconstruction; several
techniques have been described including pectoralis major ﬂap (PMF),
gastric pull-up, free jejunal transposition, and fascio-cutaneous free
ﬂaps. An important role in establishing the most appropriate type of
reconstruction is played by patient's comorbidities and speciﬁc risk
factors [36–38]. Pedicled ﬂaps, mainly the PMF, have been the ﬁrst
described for pharyngeal reconstructions, nowadays they remain the
best choice as an alternative to free ﬂaps in patients with general or
local contraindications for microsurgery [17,36,38]. Nonetheless, a
recent study compared pharyngeal reconstructions with PMF and free
ﬂaps showed no statistically signiﬁcant diﬀerences in oral re-ali-
mentation and decanulation time between the two groups; lower rate of
medical and pulmonary complications in PMF but an increase of sur-
gical ones. An explanation of these results may be the loss of suture
tightness with subsequent onset of pharyngo-cutaneous ﬁstulas and
pharyngo-esophageal strictures due to PMF excessive thickness and
weight. Concerning reconstructive procedures requiring a surgical
weakening of digestive tract; major reconstructive procedures requiring
laparotomy or laparoscopy may deplete their functional reserve and
further impact their general status. In particular, free jejunal transpo-
sition is frequently associated with postoperative ileus, potentially
leading to major complications, prolonged recovery, and longer hos-
pital stay. Nouraei et al. recently evaluated 1589 pharyngo-lar-
yngectomies suggesting that post-treatment complications occur fre-
quently and increase short- and long-term mortality. Choice of
reconstruction, and speciﬁcally the use of alimentary tract conduits,
worsens short- and long-term survival. This may be due to added
physiological stress the patient is placed under because of the opening
of abdominal or thoracic and abdominal cavities [39]. Functional re-
sults are, in the best-case scenario, comparable with those obtained
using fasciocutaneous free ﬂaps. Currently, fasciocutaneous free ﬂaps,
in particular radial forearm (RF) and anterolateral thigh [24,38,40] are
considered among the main options for such a reconstructive purpose.
Piazza et al. showed that ﬁrst-line application of RF and ALT free ﬂaps
with long-lasting salivary by-pass stent in reconstruction after partial or
total pharyngo-laryngectomy allows obtaining reduced incidences of
both ﬁstula and stenosis [24]. Nouraei et al. [39] supported the use of
free ﬂaps even in terms of overall survival regardless of tumor stage
(p < 0.05). The treatment sequence should be taken in account; our
believe, conﬁrmed by literature, is that primary deﬁnitive radiotherapy
followed by salvage surgery when indicated, is inferior in terms of
survival and functional outcome [41]. Nonetheless, treatment with
radiotherapy alone is reported to have a worse prognosis compared
with combined treatment with surgery and radiotherapy, particularly in
stage IV [2,42,43]. The only patient of the series treated after radiation
failure died after 18months because of a local relapse, moreover both
decanulation and gastrostomy tube removal had been impossible to
achieve before the fatality. This result follows the literature impression,
even if statistical signiﬁcance has not been obtained, this results is
probably due to the ﬂap impairment related to post-radiotherapy vessel
depletion. Numerous open techniques initially described for laryngeal
tumors were extended to encompass the resection of HPC, however
traditional horizontal partial techniques often remove wide portions of
healthy laryngeal structures not to get a resection free margin but to
allow the reconstruction through a pexis. Our surgical approach is
centered on obtaining an oncologically sound resection around the
tumor rather that performing a standard predetermined partial phar-
yngo-laryngectomy, the resulting defect is reconstructed with the
transposition of an infrahyoid ﬂap. This myocutaneous pedicled ﬂap, is
thin and pliable ﬂap and can usually provide a skin island of about
7×4 cm from the central part of the anterior neck; in our series the
skin paddle was usually smaller (about 6×3 cm) and then further
tailored on defect dimensions. In our cohort our surgical approach
demonstrated to be eﬀective, ensuring timely healing and adequate
functional results. In fact 91% of patients beneﬁtted of the tra-
cheostomy closure. Among patients with no respiratory risks, the can-
nula has been removed after 18 ± 8.63 days, and 75% of the patients
returned to oral feeding. Takes et al. compared the overall survival and
disease free survival of twenty retrospective studies conducted with the
diﬀerent techniques [24] paralleling the oncological results, we can
spot that our series, with 54.4% as 5-year overall survival and 61.4% 5-
year disease-free interval is comparable to the endoscopic transoral
series (Table 3).
We estimate that a reconstruction with a ﬂap whether is pedicled or
free permits a faster healing in order to begin as soon as possible the
adjuvant therapies. In fact, compared a primary closure, the risk of
pharyngeal ﬁstula is reduced and related complications are lower. In
addition, the functional results are better. Flap allows to restore the
anatomy and to avoid retraction and stricture of pharynx. The most
popular method for the management of defects in the head and neck
area is represented by free ﬂaps. However, in elderly patients or with
comorbidities this reconstructive method is not adapted with a high risk
of post-operative complications increase in the duration of stay and
ﬁnally delay to adjuvant treatment. The infra-hyoid ﬂap is proposed
here as an alternative to free ﬂaps. The simply and fast harvesting of the
procedure represents a real advantage. In precedent publication [44]
Table 3
Partial pharyngo-laryngectomy series survival rates.
Treatment No. of
patients
Overall survival
5 year (4 year)
[3 year] -2 year-
Disease-speciﬁc
survival
5 year (4 year)
[3 year]
Open procedures
Ogura et al. 85 [59%] –
Lacourreye et al. 34 (T2) – 56%
Chevalier et al. 48 (T1/T2) 47% –
T1: 78%
T2: 38%
Makeieﬀ et al. 87 (T1/T2) 60% –
Plouin-Gaudon et al. 34 50% 65%
Steiner et al. 129 71% (stage I/II) 95% (stage I/II)
47% (stage III/IV) 69% (stage III/IV)
Rudert et al. 29 48% 58%
Vilaseca et al. 28 (43%) (59%)
Kutter et al. 58 -78%- –
Martin et al. 172 68% (stage I/II) 96% (stage I/II)
64% (stage III) 86% (stage III)
41% (stage IV) 57% (stage IV)
Dolivet et al. 57 (stage III/
IV)
54% 61%
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there was no signiﬁcant diﬀerence in terms of postoperative compli-
cations, functionality and prognosis between pedicled ﬂap and free ﬂap
for head and neck reconstruction. However, the infrahyoid ﬂap oﬀers a
reduced thickness and bulkiness compared to PMF and this is probably
the explanation in avoiding high rate of pharyngo-cutaneous ﬁstula and
pharyngo-esophageal strictures. On the other hand, the major contra-
indication in using the infrahyoid ﬂap is due to its limited surface if
compared to PMF or free ﬂaps especially in covering defects reaching
the cervical esophagus. Another point is the impossibility of using the
ﬂap as a backup in already surgically treated neck and an increased risk
of failure in previous CCRT that compromises the quality of neck tis-
sues. The limits of this ﬂap are: the dimensional limitations, in our and
most other series the average dimensions of the ﬂap is 7×4 cm, pre-
vious thyroid surgery or neck dissection, and N3 neck metastasis. We
consider that previous radiotherapy is not an absolute contraindication
if the appearance of the cervical skin is normal, without ﬁbrosis or
teleangiectasias. Otherwise, the infrahyoid ﬂap must be always be
planned in advance.
5. Conclusion
Our series presented oncological and functional results comparable
to the others wide series described in literature. The infrahyoid ﬂap is a
useful surgical instrument in hypopharyngeal reconstruction after par-
tial pharyngo-laryngectomies and it should be considered, especially in
case of general or local contraindications for microsurgery, as a smaller
and lighter alternative to pectoralis major ﬂap.
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